These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4579972)

  • 1. Efficacy and safety of metolazone in renal failure and the nephrotic syndrome.
    Bennett WM; Porter GA
    J Clin Pharmacol; 1973; 13(8):357-64. PubMed ID: 4579972
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of metolazone in patients with renal edema.
    Dargie HJ; Allison ME; Kennedy AC; Gray MJ
    Clin Nephrol; 1974; 2(4):157-60. PubMed ID: 4847130
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of metolazone, a new diuretic, in patients with renal disease.
    Craswell PW; Ezzat E; Kopstein J; Varghese Z; Moorhead JF
    Nephron; 1974; 12(1):63-73. PubMed ID: 4838012
    [No Abstract]   [Full Text] [Related]  

  • 4. High dosage metolazone in chronic renal failure.
    Dargie HJ; Allison ME; Kennedy AC; Gray MJ
    Br Med J; 1972 Oct; 4(5834):196-8. PubMed ID: 5082545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome.
    Paton RR; Kane RE
    J Clin Pharmacol; 1977 Apr; 17(4):243-51. PubMed ID: 849998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of metolazone in the long-term treatment of essential hypertension.
    Cangiano JL; Campos JA; Trevino A; Ramirez-Gonzalez R; Ramirez-Muzo O
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):778-85. PubMed ID: 4217244
    [No Abstract]   [Full Text] [Related]  

  • 7. Metolazone and spironolactone in cirrhosis and the nephrotic syndrome.
    Lang GR; Westenfelder C; Nascimento L; Dhupelia VB; Arruda JA; Kane RE
    Clin Pharmacol Ther; 1977 Feb; 21(2):234-43. PubMed ID: 319937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of metolazone (zaroxolyn).
    Materson BJ; Oster JR; Perez-Stable EC
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):890-6. PubMed ID: 4214663
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with metolazone in fifty-two African patients: synergy with frusemide.
    Gunstone RF; Wing AJ; Shani HG; Njemo D; Sabuka EM
    Postgrad Med J; 1971 Dec; 47(554):789-93. PubMed ID: 5138749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technique of controlled drug assay in hypertension. V. Comparison of hydrochlorothiazide with a new quinethazone diuretic, metolazone.
    Pilewski RM; Scheib ET; Misage JR; Kessler E; Krifcher E; Shapiro AP
    Clin Pharmacol Ther; 1971; 12(5):843-8. PubMed ID: 4936150
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
    Lowenthal DT; Shear L
    Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction studies with metolazone, ouabain and lidocaine.
    Yelnosky J; Borrelli A; Kaiser F; Belair E
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):93-101. PubMed ID: 5031582
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute effects of metolazone on electrolyte and acid excretion in man.
    Smiley JW; Onesti G; Swartz C
    Clin Pharmacol Ther; 1972; 13(3):336-42. PubMed ID: 5026375
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and biochemical evaluation of a new diuretic agent (Metolazone).
    Keogh B; Carmody M; Malone D; O'Dwyer WF
    J Ir Med Assoc; 1971 May; 64(412):255-60. PubMed ID: 5579602
    [No Abstract]   [Full Text] [Related]  

  • 16. Diuretics. II. Clinical considerations.
    Anderton JL; Kincaid-Smith P
    Drugs; 1971; 1(2):141-65. PubMed ID: 4939014
    [No Abstract]   [Full Text] [Related]  

  • 17. Mefruside: a preliminary report of its pharmacological properties and therapeutic efficacy in oedema and hypertension.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1974; 7(6):419-25. PubMed ID: 4609331
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative pharmacodynamics of torasemide and furosemide in patients with oedema.
    Herchuelz A; Deger F; Douchamps J; Ducarne H; Broekhuysen J
    Arzneimittelforschung; 1988 Jan; 38(1A):180-3. PubMed ID: 3285831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose comparison of torasemide and furosemide in patients with advanced renal failure.
    Klütsch K; Grosswendt J; Haecker W
    Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of diuretics in chronic renal insufficiency and nephrotic syndrome.
    Brater DC
    Semin Nephrol; 1988 Dec; 8(4):333-41. PubMed ID: 3068754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.